HIVPxResearch 161d ago

First developed in 2024 in partnership with global advocates and communities, the People’s Research Agenda sets out a people-centered framework for equitable and accelerated R&D and product introduction. The PRA tracks the science, shows where investments align—or fail to align—with community-defined priorities, and spotlights critical gaps in the pipeline of prevention options needed to meet the diverse realities of all populations. Featured speaker Jeanne Marrazzo, CEO of the Infectious Diseases Society of America and AVAC board member. We will cover what the People’s Research Agenda tracks, why it matters, and the advocacy priorities that will shape the future of prevention R&D.